Banner - NPPA Connect

Opinion|Videos|July 3, 2024

Vitiligo in a 35-Year-Old Female: Case-Based Discussion, Treatment Sequencing, and Practical Insights

Author(s)Latanya Benjamin, MD, FAAD, FAAP

Dr. Latanya Benjamin, MD, FAAD, FAAP, continues her discussion on a 35-year-old female patient with vitiligo by analyzing laboratory workup results and exploring advanced treatment decisions to optimize patient outcomes.

Episodes in this series

Latanya Benjamin, MD, FAAD, FAAP, an expert on vitiligo

EP. 1 Patient vs Provider Perceptions: Expert Opinions on Addressing the Emotional Impact of Vitiligo

Latanya Benjamin, MD, FAAD, FAAP, an expert on vitiligo

EP. 2 Vitiligo in a 35-Year-Old Female: Case-Based Discussion, Treatment Sequencing, and Practical Insights

Latanya Benjamin, MD, FAAD, FAAP, an expert on vitiligo

EP. 3 Vitiligo Case-Based Discussion: Impact of Stigma, Social Perception, and Practical Management Strategies

Latanya Benjamin, MD, FAAD, FAAP, an expert on vitiligo

EP. 4 Topical Ruxolitinib in Vitiligo: Efficacy, Regional Approvals, and Treatment Strategies in African American Patients

EP. 5 Vitiligo Care Personalized for Each Patient: Part 2

EP. 5 Vitiligo Care Personalized for Each Patient: Part 2

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

Noninvasive Imaging Maps Repigmentation and Melanocyte Activation in Ruxolitinib-Treated Vitiligo

ByMarie Bosslett, Assistant Editor

August 24th 2026

Dermatology Times Spot Test: August 23, 2026

ByMarie Bosslett, Assistant Editor

August 23rd 2026

Meta-Analysis Finds Significantly Lower SCC Risk in Patients With Vitiligo

ByMarie Bosslett, Assistant Editor

August 20th 2026

How to Explain JAK Inhibitor Safety to Patients

ByLisa Swanson, MD, FAAD,Shannon Heaning, Content Associate

July 31st 2026

Ritlecitinib Meets Co-Primary End Points in Phase 3 Nonsegmental Vitiligo Trials

ByKaitlyn Bader, Assistant Managing Editor

July 30th 2026

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline

Uncovering the Autoimmune Links & Systemic Impact of Chronic Spontaneous Urticaria

10 Skin Cancer Exam Tips

Early Recognition and Psychosocial Impact in Male Pattern Hair Loss

Journal Digest: September 2, 2026